Close Menu

NEW YORK — A new comparison of 10 commercial SARS-CoV-2 antibody tests revealed significant variation in accuracy between different assays, with rapid lateral flow immunoassays (LFIAs) among the best performers.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.